Pediatric Antiepileptic Drug Treatment Recommendations

First-Line Treatment Selection

The American Academy of Pediatrics recommends carbamazepine as the preferred first-line agent for children with partial onset seizures due to its established efficacy and favorable side effect profile 1
Levetiracetam represents an effective alternative with excellent tolerability for pediatric patients with partial onset seizures 1
Valproate dosing is 20-30 mg/kg at 40 mg/min for acute treatment, though it should be avoided in young children when possible due to hepatotoxicity risk 1

The American Academy of Pediatrics advises avoiding valproic acid in young children due to significant hepatotoxicity risk 1
Phenobarbital may be considered for infants but carries substantial risk of behavioral adverse effects 1

The American College of Emergency Physicians recommends administering either valproate or levetiracetam as second-line agents with equivalent efficacy when seizures persist despite optimal benzodiazepine dosing 2, 3
Levetiracetam 30 mg/kg IV at 5 mg/kg per minute demonstrates a 73% response rate in refractory status epilepticus 3
Valproate 30 mg/kg IV at 6 mg/kg/hour achieves 88% seizure control within 20 minutes and 79% control as a second-line agent versus 25% with phenytoin 4, 3
Both agents show similar efficacy: levetiracetam 47% versus valproate 46% cessation at 60 minutes in status epilepticus 2

The American Academy of Pediatrics advises never using polytherapy when monotherapy can achieve seizure control to minimize adverse effects and drug interactions 1
The American Academy of Pediatrics recommends not prescribing antiepileptic drugs routinely after a first unprovoked seizure 1
The American College of Obstetricians and Gynecologists advises avoiding valproic acid in women of childbearing potential due to teratogenic risk 1
The American Academy of Pediatrics recommends not using prophylactic anticonvulsants in patients with no seizure history, as they do not reduce first seizure risk 5

The American Academy of Pediatrics recommends considering discontinuation after 2 seizure-free years, taking into account clinical, social, and personal factors 1
For patients requiring ongoing treatment, the American Academy of Pediatrics advises transitioning to oral formulations of the medication that controlled the acute seizure 5

The American College of Emergency Physicians recommends initial stabilization, ensuring airway, breathing, circulation, followed by first-line IV benzodiazepines (lorazepam preferred for longer duration of action) 5
If seizures persist, the American College of Emergency Physicians advises choosing between valproate (30 mg/kg IV) or levetiracetam (30 mg/kg IV) based on age, previous medication response, comorbidities, and gender 1, 3, 4, 5